Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  donor lymphocytes
Find trials that include:  Any drugs shown
Results 1-9 of 9 for your search:
Start Over
AP1903 and Genetically Modified Donor T Cells after Donor Stem Cell Transplant in Treating Patients with Hematologic Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: 2012-0501, NCI-2013-01666, RM00000684-RN00, NCT01875237
Chemotherapy and Donor Lymphocytes in Treating Older Patients with High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 55 and over
Trial IDs: Pro00043247, NCI-2014-00663, NCT02046122
Recombinant Interleukin-15 and Donor Natural Killer Cell Therapy in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2010LS063, NCI-2011-01081, 1009M89012, MT2010-10, NCT01385423
Donor CD8+ Memory T-cells in Treating Patients with Relapsed Hematolymphoid Malignancies
Phase: Phase I
Type: Supportive care, Treatment
Age: 18 to 75
Trial IDs: BMT243, NCI-2012-00044, BMT243-DONOR, SU-01272012-9028, NCT01523223
Donor Lymphocyte Infusion in Treating Patients Previously Treated with Donor Stem Cell Transplant
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00003975, NCI-2013-00567, NCT01627275
Donor Lymphocytes after Combination Chemotherapy in Treating Patients with Acute Myeloid Leukemia
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and older
Trial IDs: 021208, NCI-2013-02408, CINJ# 021208, FWA00003913, Pro2013002693, NCT02105116
Donor Stem Cell Transplant in Treating Patients with Non-malignant Hematologic Disorders
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 55 and under
Trial IDs: 2014OC034, NCI-2014-02311, 1407M52125, MT2014-10C, NCT02179359
Start Over